BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7915830)

  • 1. c-erbB-2 oncogene expression in salivary gland tumours.
    Kärjä V; Syrjänen S; Kataja V; Syrjänen K
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(4):206-12. PubMed ID: 7915830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low p53 protein expression in salivary gland tumours compared with lung carcinomas.
    Soini Y; Kamel D; Nuorva K; Lane DP; Vähäkangas K; Pääkkö P
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):415-20. PubMed ID: 1333678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
    Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
    Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of c-erbB-2 oncoprotein in salivary gland tumours: an immunohistochemical study.
    Kernohan NM; Blessing K; King G; Corbett IP; Miller ID
    J Pathol; 1991 Jan; 163(1):77-80. PubMed ID: 1672154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
    Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C
    J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and mutations of p53 in salivary gland tumours.
    Kärjä VJ; Syrjänen KJ; Kurvinen AK; Syrjänen SM
    J Oral Pathol Med; 1997 May; 26(5):217-23. PubMed ID: 9178173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary gland tumors: immunohistochemical study of EGF, EGFR, ErbB-2, FAS and Ki-67.
    Ito FA; Ito K; Coletta RD; Graner E; de Almeida OP; Lopes MA
    Anal Quant Cytol Histol; 2009 Oct; 31(5):280-7. PubMed ID: 20701095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
    Monteiro LS; Bento MJ; Palmeira C; Lopes C
    J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of C-KIT (CD117) molecule in benign and malignant salivary gland tumours.
    Andreadis D; Epivatianos A; Poulopoulos A; Nomikos A; Papazoglou G; Antoniades D; Barbatis C
    Oral Oncol; 2006 Jan; 42(1):57-65. PubMed ID: 16140564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenascin in salivary gland tumours.
    Soini Y; Pääkkö P; Virtanen I; Lehto VP
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(3):217-22. PubMed ID: 1384222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of intermediate-sized filaments in sialadenoma papilliferum and other salivary gland neoplasms.
    Nakahata A; Deguchi H; Yanagawa T; Yoshida H; Sato M; Hayashi Y
    J Oral Pathol Med; 1990 Aug; 19(7):313-8. PubMed ID: 1700116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of claudin-4 in salivary gland neoplasms (a study utilizing RT-PCR and immunohistochemistry).
    Abd El-Ghani SF; Kasem RF; Ghallab NA; Shaker OG
    J Oral Pathol Med; 2013 Nov; 42(10):781-7. PubMed ID: 23614611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis is inversely related to bcl-2 but not to bax expression in salivary gland tumours.
    Soini Y; Törmänen U; Pääkkö P
    Histopathology; 1998 Jan; 32(1):28-34. PubMed ID: 9522213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological pattern of salivary gland tumours.
    Gill MS; Muzaffar S; Soomro IN; Kayani N; Hussainy AS; Pervez S; Hasan SH
    J Pak Med Assoc; 2001 Oct; 51(10):343-6. PubMed ID: 11768933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoexpression of c-erbB-2 and p53 in benign and malignant salivary neoplasms with myoepithelial differentiation.
    Rosa JC; Félix A; Fonseca I; Soares J
    J Clin Pathol; 1997 Aug; 50(8):661-3. PubMed ID: 9301549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypical profiles of salivary gland tumours: a new evidence for their histogenetic origin.
    Gürbüz Y; Yildiz K; Aydin O; Almaç A
    Pathologica; 2006 Apr; 98(2):147-52. PubMed ID: 16929788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiological evaluation of salivary gland tumors in the Wrocław ENT Department patients in the years 2001-2010].
    Kubacka M; Orendorz-Frączkowska K; Pazdro-Zastawny K; Morawska-Kochman M; Kręcicki T
    Otolaryngol Pol; 2013; 67(1):30-3. PubMed ID: 23374661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical analysis of salivary gland tumor cases in West China in past 50 years.
    Li LJ; Li Y; Wen YM; Liu H; Zhao HW
    Oral Oncol; 2008 Feb; 44(2):187-92. PubMed ID: 17418612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of c-erbB-2 amplification in salivary gland tumours by differential polymerase chain reaction.
    Birek C; Lui E; Jordan RC; Dardick I
    Eur J Cancer B Oral Oncol; 1994 Jan; 30B(1):47-50. PubMed ID: 9135973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of C-erbB-2 oncogene mRNA in salivary gland tumors].
    Sun H; Wu S; Ouyang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):289-91. PubMed ID: 11776895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.